Signs You Need Coenzyme Q10: Deficiency and Who Benefits
Coenzyme Q10 (CoQ10), also known as ubiquinone, is a fat-soluble compound found in virtually every cell of the body. It serves two primary functions: as a critical component of the mitochondrial electron transport chain (the machinery that produces ATP — the cell's energy currency) and as a powerful antioxidant that protects cell membranes from oxidative damage.
Unlike many nutrients, CoQ10 is synthesised by the body itself. However, synthesis declines with age, and certain medications — most notably statins — significantly suppress endogenous CoQ10 production. This makes understanding CoQ10 status practically important for many people.
Deficiency Symptoms
Primary CoQ10 deficiency is rare and typically genetic. Secondary or functional deficiency — where levels fall below optimal without a genetic cause — is more common and associated with:
- Fatigue and exercise intolerance – the most commonly reported symptom; cells in high-energy tissues (heart, muscles, brain) are most sensitive to reduced CoQ10
- Muscle weakness and pain (myopathy) – particularly relevant in people taking statin medications
- Cognitive symptoms – brain fog, difficulty concentrating; CoQ10 is highly concentrated in the brain
- Cardiovascular symptoms – reduced CoQ10 levels are consistently found in patients with heart failure (Mortensen et al., 2014)
- Higher susceptibility to oxidative stress – manifesting as accelerated cellular ageing, though this is difficult to measure clinically
At-Risk Groups
Statin Users
This is the most clinically significant group. Statins block the mevalonate pathway — the same pathway used to synthesise both cholesterol and CoQ10. Patients on statins frequently report muscle symptoms, and while the overall evidence for statin-induced CoQ10 depletion is debated, it is a well-recognised mechanistic concern. Some studies suggest that CoQ10 supplementation may help relieve muscle symptoms in statin users (Bookstaver et al., 2012).
Older Adults
Endogenous CoQ10 synthesis declines with advancing age, and tissue concentrations decrease in the heart, liver, and other organs. The reduction is well-documented, though its clinical significance in otherwise healthy older adults is still under study.
People with Heart Failure
CoQ10 levels are reduced in proportion to the severity of heart failure. A randomised controlled trial (the Q-SYMBIO trial) found that CoQ10 supplementation significantly reduced major cardiac events and mortality in patients with chronic heart failure (Mortensen et al., 2014). This is one of the stronger pieces of clinical evidence for CoQ10 supplementation in any specific group.
Individuals with Mitochondrial Diseases
Primary mitochondrial disorders are a recognised indication for CoQ10 supplementation, guided by specialist physicians.
Athletes Concerned with Oxidative Stress
Intense exercise increases oxidative stress. CoQ10 may support recovery in this context, though robust evidence for performance enhancement in already-healthy athletes is limited.
How Is CoQ10 Status Tested?
Blood CoQ10 levels can be measured, but reference ranges vary between laboratories and there is no universal consensus on what constitutes "deficiency" in healthy individuals. Testing is most useful in the specific clinical contexts above (statin users with muscle symptoms, heart failure patients) rather than for routine assessment.
The Nordic and Estonian Context
In Northern Europe, CoQ10 is not typically measured in routine health screening. Statin use is, however, common — cardiovascular disease risk is a relevant concern in the Estonian population. For Estonians on statins who experience unexplained fatigue or muscle pain, CoQ10 supplementation is a reasonable consideration to discuss with a doctor.
Dietary sources of CoQ10 include organ meats, beef, sardines, mackerel, and peanuts. The amounts obtainable from food are modest relative to what supplementation provides.
When to Supplement vs When Diet Is Enough
For healthy young adults with no specific risk factors, CoQ10 synthesis is generally adequate and supplementation is not well-supported by evidence. Consider supplementation if you:
- Are taking statins and experience muscle symptoms
- Have a diagnosis of heart failure (discuss with your cardiologist)
- Are over 50 and have cardiovascular risk factors
- Have a mitochondrial disease (specialist-guided only)
Ubiquinol (the reduced, active form of CoQ10) may have advantages over ubiquinone in certain populations, particularly older adults where conversion capacity is reduced.
At maxfit.ee you will find products such as ICONFIT Capsules Coenzyme Q10 90caps, OstroVit Ubichinon Q10 100mg 60caps, and MST Coenzyme Q10 100mg 60caps.
See the full range in our CoQ10 category.
FAQ
Does CoQ10 give you energy?
CoQ10 supports mitochondrial energy production — it is a required component of the process. In people with genuinely depleted CoQ10 (statin users, older adults, heart failure patients), supplementation may improve energy. In well-nourished healthy young adults, evidence for an energy-boosting effect is limited.
Is CoQ10 safe?
CoQ10 is well tolerated at supplemental doses. Occasional mild gastrointestinal symptoms (nausea, stomach upset) are the most reported side effects. It may have a mild blood pressure-lowering effect — relevant if you are on antihypertensive medication.
How long does it take for CoQ10 to work?
Benefits in relevant clinical contexts (statin myopathy, heart failure) have generally been observed over weeks to months in published trials. Do not expect immediate effects.
References
Mortensen, S. A., Rosenfeldt, F., Kumar, A., Dolliner, P., Filipiak, K. J., Pella, D., ... & Swedberg, K. (2014). The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC: Heart Failure, 2(6), 641-649. https://pubmed.ncbi.nlm.nih.gov/25282031/
Bookstaver, D. A., Burkhalter, N. A., & Hatzigeorgiou, C. (2012). Effect of coenzyme Q10 supplementation on statin-induced myalgias. American Journal of Cardiology, 110(4), 526-529. https://pubmed.ncbi.nlm.nih.gov/22608359/
Mitchell, P. (2011). Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biochimica et Biophysica Acta, 1807(12), 1507-1538. https://pubmed.ncbi.nlm.nih.gov/22082452/
